Abstract
Aim
It has been reported that Ginkgo biloba extract (GBE) is an inducer or inhibitor of microsomal cytochrome P450 (CYP) 2C19, and diazepam is a substrate of CYP2C19. Thus, it could be expected that GBE may alter the metabolism of diazepam.
Methods
The pharmacokinetic parameters of diazepam and one of its metabolites, N-demethyldiazepam, were compared after oral administration of diazepam (10 mg) in the absence or presence of oral GBE (120 mg bid, for 28 days) in 12 healthy volunteers. The pharmacokinetic analysis was performed using a noncompartmental method.
Results
The 90% confidence intervals (CIs) of the ratios of mean pharmacokinetic parameters of diazepam presence and absence of GBE were well within the 80–125% bioequivalence range, indicating no pharmacokinetic interaction. The ratio of AUC0–408 with GBE to AUC0–408 without GBE was 95.2 (90%CI: 91.6–98.8) and 101.8 (90%CI: 99.4–104.1) for diazepam and N-desmethyldiazepam, respectively. The two drugs were well tolerated, and no drug-related serious adverse events were reported.
Conclusion
The above data suggest that GBE, when taken in normally recommended doses over a 4-week time period, may not affect the pharmacokinetics of diazepam via CYP2C19 and the excretion of N-desmethyldiazepam in healthy volunteers. No drug-drug interaction was observed between GBE and diazepam.
Similar content being viewed by others
References
Diamond BJ, Shiflett SC, Feiwel N, Matheis RJ, Noskin O, Richards JA et al (2000) Ginkgo biloba extract: mechanisms and clinical indications. Arch Phys Med Rehabil 81(5):668–678
Joshi BS, Kaul PN (2001) Alternative medicine: herbal drugs and their critical appraisal—part I. Prog Drug Res 56:1–76
Koltermann A, Hartkorn A, Koch E, Fürst R, Vollmar AM, Zahler S (2007) Ginkgo biloba extract EGb 761 increases endothelial nitric oxide production in vitro and in vivo. Cell Mol Life Sci 64(13):1715–1722
Mahmoud F, Abul H, Onadeko B, Khadadah M, Hainea D, Morgan G (2000) In vitro effects of ginkgolide B on lymphocyte activation in atopic asthma: comparison with cyclosporin A. Jpn J Pharmacol 83(3):241–245
Louajri A, Harraga S, Godot V, Toubin G, Kantelip JP, Magnin P (2001) Biol Pharm Bull 24(6):710–712
Kisli E, Ozdemir H, Kösem M, Sürer H, Ciftçi A, Kanter M (2007) Effect of Ginkgo biloba extract (EGb 761) on the healing of left colonic anastomoses in rat. World J Surg 31(8):1652–1657
Kennedy DO, Scholey AB, Wesnes KA (2000) The dose-dependent cognitive effects of acute administration of Ginkgo biloba to healthy young volunteers. Psychopharmacology (Berl) 151(4):416–423
Polich J, Gloria R (2001) Cognitive effects of a Ginkgo biloba/vinpocetine compound in normal adults: systematic assessment of perception, attention and memory. Hum Psychopharmacol 16(5):409–416
Gurley BJ, Gardner SF, Hubbard MA, Williams DK, Gentry WB, Cui Y et al (2002) Cytochrome P450 phenotypic ratios for predicting herb–drug interactions in humans. Clin Pharmacol Ther 72(3):276–287
Markowitz JS, Donovan JL, DeVane CL, Spikes L, Chavin KD (2003) Multiple dose administration of Ginkgo biloba did not affect cytochrome P-450 2D6 or 3A4 activity in normal volunteers. J Clin Psychopharmacol 23(6):576–581
He N, Xie HG, Collins X, Edeki T, Yan Z (2006) Effects of individual ginsenosides, ginkgolides and flavonoids on CYP2C19 and CYP2D6 activity in human liver microsomes. Clin Exp Pharmacol Physiol 33(9):813–815
Zou L, Harkey MR, Henderson GL (2002) Effects of herbal components on cDNA-expressed cytochrome P450 enzyme catalytic activity. Life Sci 71(13):1579–1589
Yin OQ, Tomlinson B, Waye MM, Chow AH, Chow MS (2004) Pharmacogenetics and herb-drug interactions: experience with Ginkgo biloba and omeprazole. Pharmacogenetics 14(12):841–850
Mandelli M, Tognoni G, Garattini S (1978) Clinical pharmacokinetics of diazepam. Clin Pharmacokinet 3(1):72–91
Bertilsson L, Henthorn TK, Sanz E, Tybring G, Sawe J, Villen T (1989) Importance of genetic factors in the regulation of diazepam metabolism: relationship to S-mephenytoin, but not debrisoquin, hydroxylation phenotype. Clin Pharmacol Ther 45(4):348–355
Jung F, Richardson TH, Raucy JL, Johnson EF (1997) Diazepam metabolism by cDNA expressed human 2C P450s: identification of P4502C18 and P4502C19 as low K(M) diazepam N-demethylases. Drug Metab Dispos 25(2):133–139
Yang TJ, Krausz KW, Sai Y, Gonzalez FJ, Gelboin HV (1999) Eight inhibitory monoclonal antibodies define the role of individual P-450 s in human liver microsomal diazepam, 7-ethoxycoumarin, and imipramine metabolism. Drug Metab Dispos 27(1):102–109
Jack ML, Colburn WA (1983) Pharmacokinetics model for diazepam and its major metabolite desmethyldiazepam following diazepam administration. J Pharm Sci 72(11):1318–1323
Greenblatt DJ, Divoll MK, Soong MH, Boxenbaum HG, Harmatz JS, Shader RI (1988) Desmethyldiazepam pharmacokinetics: studies following intravenous and oral desmethyldiazepam and clorazepate, and intravenous diazepam. J Clin Pharmac 28(9):853–859
Zhang SG, Chen ML, Tang YN (2004) Determination of urinary hydrocortisone and 6β-hydroxycortisol by HPLC. Chin Hosp Pharm J 24(12):733–735
Biber A (2003) Pharmacokinetics of Ginkgo biloba extracts. Pharmacopsychiatry 36(Suppl 1):S32–S37
Fourtillan JB, Brisson AM, Girault J, Ingrand I, Decourt JP, Drieu K et al (1995) Pharmacokinetic properties of bilobalide and ginkgolides A and B in healthy subjects after intravenous and oral administration of Ginkgo biloba extract (EGb 761). Therapie 50(2):137–144
Perucca E, Gatti G, Cipolla G, Spina E, Barel S, Soback S et al (1994) Inhibition of diazepam metabolism by fluvoxamine: A pharmacokinetc study in normal volunteers. Clin Pharmaol Ther 56(5):471–476
Acknowledgments
We are grateful to Yangzijiang Pharmaceutical (China) for supplying the GBE tablets, and Professor Yurong Zhang of the Institute of Criminal Science and Technology in Shanghai Public Security Bureau for N-desmethyldiazepam provision and for facilitating the whole project. This work was supported by China Hunan Provincial Health Department Project (no. B2006-083).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zuo, XC., Zhang, BK., Jia, SJ. et al. Effects of Ginkgo biloba extracts on diazepam metabolism: a pharmacokinetic study in healthy Chinese male subjects. Eur J Clin Pharmacol 66, 503–509 (2010). https://doi.org/10.1007/s00228-010-0795-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-010-0795-4